Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

China Pharma Holdings Inc (NYSE MKT LLC:CPHI)

0.28
Delayed Data
As of Jul 29
 0.00 / 0.00%
Today’s Change
0.12
Today|||52-Week Range
0.35
+78.46%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Generic
MARKET CAP
$12.0M

Company Description

China Pharma Holdings, Inc. engages in the development, manufacturing, packaging, marketing and distribution of generic and branded pharmaceutical products for a range of high incidence and high mortality conditions. It focuses on its therapeutics include CNS, cardiovascular, cerebrovascular, wound recovery, digestive disease, and infectious diseases. It manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, oral solutions and granules. The company was founded by Zhilin Li on January 28, 1999 and is headquartered in Haikou, China

Contact Information

China Pharma Holdings, Inc.
2nd floor, Jiahai Building
Haikou Hainan 570216
P:8689866811730
Investor Relations:

Employees

Shareholders

Individual stakeholders44.69%
Mutual fund holders--
Other institutional--

Top Executives

Zhilin LiChairman, President, Chief Executive Officer & CFO
Yao HuangChief Technology Officer
Na HuangManager-Investor Relations
Jian YangSecretary